Occudo Quantitative Strategies LP Boosts Holdings in CorVel Co. (NASDAQ:CRVL)

Occudo Quantitative Strategies LP increased its holdings in CorVel Co. (NASDAQ:CRVL) by 184.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,467 shares of the business services provider’s stock after buying an additional 2,896 shares during the quarter. Occudo Quantitative Strategies LP’s holdings in CorVel were worth $497,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Fifth Third Bancorp raised its stake in CorVel by 45.9% during the 4th quarter. Fifth Third Bancorp now owns 321 shares of the business services provider’s stock worth $36,000 after acquiring an additional 101 shares during the period. LGT Financial Advisors LLC raised its stake in CorVel by 200.0% during the 4th quarter. LGT Financial Advisors LLC now owns 255 shares of the business services provider’s stock worth $28,000 after acquiring an additional 170 shares during the period. Franklin Resources Inc. raised its stake in CorVel by 9.9% during the 3rd quarter. Franklin Resources Inc. now owns 1,917 shares of the business services provider’s stock worth $614,000 after acquiring an additional 173 shares during the period. Bessemer Group Inc. raised its stake in CorVel by 6,350.0% during the 4th quarter. Bessemer Group Inc. now owns 258 shares of the business services provider’s stock worth $29,000 after acquiring an additional 254 shares during the period. Finally, US Bancorp DE raised its stake in CorVel by 225.4% during the 4th quarter. US Bancorp DE now owns 384 shares of the business services provider’s stock worth $43,000 after acquiring an additional 266 shares during the period. Hedge funds and other institutional investors own 51.36% of the company’s stock.

Insider Activity

In related news, Director Jeffrey J. Michael sold 16,523 shares of the business’s stock in a transaction on Wednesday, April 9th. The shares were sold at an average price of $116.99, for a total value of $1,933,025.77. Following the sale, the director now owns 551,787 shares in the company, valued at approximately $64,553,561.13. The trade was a 2.91% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Alan Hoops sold 10,200 shares of the business’s stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $116.39, for a total transaction of $1,187,178.00. Following the completion of the sale, the director now owns 118,213 shares in the company, valued at $13,758,811.07. This represents a 7.94% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 37,200 shares of company stock worth $4,340,250 over the last quarter. Insiders own 47.57% of the company’s stock.

Wall Street Analyst Weigh In

Separately, StockNews.com upgraded shares of CorVel from a “hold” rating to a “buy” rating in a research report on Friday, April 18th.

CorVel Price Performance

CorVel stock opened at $110.03 on Friday. The stock has a market cap of $5.65 billion, a P/E ratio of 64.72 and a beta of 1.10. CorVel Co. has a 1 year low of $76.53 and a 1 year high of $128.61. The firm’s 50 day moving average price is $111.05 and its 200-day moving average price is $116.27.

CorVel Profile

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.